Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies

Purpose. To review the risk factors and pathogenesis of endothelial decompensation after penetrating keratoplasty (PKP) and its novel therapeutic strategies. Methods. Literature review. Results. As the major cause of graft failure in PKP, endothelial decompensation of corneal allograft is considered...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengyuan Liu, Jing Hong
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2018/1389486
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563883987959808
author Mengyuan Liu
Jing Hong
author_facet Mengyuan Liu
Jing Hong
author_sort Mengyuan Liu
collection DOAJ
description Purpose. To review the risk factors and pathogenesis of endothelial decompensation after penetrating keratoplasty (PKP) and its novel therapeutic strategies. Methods. Literature review. Results. As the major cause of graft failure in PKP, endothelial decompensation of corneal allograft is considered an irreversible decrease in endothelial cell density and endothelial dysfunction. Various risk factors, including donor status and operative and recipient factors, have been found to be associated with this pathological process. Operative factors like graft size and recipient factors such as indications, glaucoma, or glaucoma surgery history are highly associated with the occurrence of endothelial decompensation, while others are still under investigation. Although the mechanism of these risk factors remains unclear, pathogenesis can be summarized as an acute and chronic loss of endothelium, and cell exchange between donor and recipient is at the core of chronic cell loss. Endothelial keratoplasty has been a useful alternative to repeat standard PKP in eyes with failed grafts. Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet’s membrane endothelial keratoplasty (DMEK) following failed PKP provide more rapid visual recovery and achieve better rates of graft survival than those of a second PKP. Conclusions. Any direct or indirect damage to the endothelium could cause the loss, morphological changes, and dysfunction of endothelial cells. Graft size, indications, and recipient glaucoma or glaucoma surgery history are risk factors for endothelial decompensation. DSAEK and DMEK are novel therapeutic strategies for failed PKP grafts and have potential superiorities compared with repeat PKP.
format Article
id doaj-art-f6828427221447408e9fa61fa46568d2
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-f6828427221447408e9fa61fa46568d22025-02-03T01:12:26ZengWileyJournal of Ophthalmology2090-004X2090-00582018-01-01201810.1155/2018/13894861389486Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic StrategiesMengyuan Liu0Jing Hong1Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, ChinaPurpose. To review the risk factors and pathogenesis of endothelial decompensation after penetrating keratoplasty (PKP) and its novel therapeutic strategies. Methods. Literature review. Results. As the major cause of graft failure in PKP, endothelial decompensation of corneal allograft is considered an irreversible decrease in endothelial cell density and endothelial dysfunction. Various risk factors, including donor status and operative and recipient factors, have been found to be associated with this pathological process. Operative factors like graft size and recipient factors such as indications, glaucoma, or glaucoma surgery history are highly associated with the occurrence of endothelial decompensation, while others are still under investigation. Although the mechanism of these risk factors remains unclear, pathogenesis can be summarized as an acute and chronic loss of endothelium, and cell exchange between donor and recipient is at the core of chronic cell loss. Endothelial keratoplasty has been a useful alternative to repeat standard PKP in eyes with failed grafts. Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet’s membrane endothelial keratoplasty (DMEK) following failed PKP provide more rapid visual recovery and achieve better rates of graft survival than those of a second PKP. Conclusions. Any direct or indirect damage to the endothelium could cause the loss, morphological changes, and dysfunction of endothelial cells. Graft size, indications, and recipient glaucoma or glaucoma surgery history are risk factors for endothelial decompensation. DSAEK and DMEK are novel therapeutic strategies for failed PKP grafts and have potential superiorities compared with repeat PKP.http://dx.doi.org/10.1155/2018/1389486
spellingShingle Mengyuan Liu
Jing Hong
Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies
Journal of Ophthalmology
title Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies
title_full Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies
title_fullStr Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies
title_full_unstemmed Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies
title_short Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies
title_sort risk factors for endothelial decompensation after penetrating keratoplasty and its novel therapeutic strategies
url http://dx.doi.org/10.1155/2018/1389486
work_keys_str_mv AT mengyuanliu riskfactorsforendothelialdecompensationafterpenetratingkeratoplastyanditsnoveltherapeuticstrategies
AT jinghong riskfactorsforendothelialdecompensationafterpenetratingkeratoplastyanditsnoveltherapeuticstrategies